Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| SECZ | Miller William Dawson | Chief Operating Officer | 09/10/2026 | Zuteilung | — | 109,913 | — | Form 4 |
| SECZ | Domingo Soriano Carlos Francisco | Executive Chairman and CEO | 09/10/2026 | Zuteilung | — | 318,302 | — | Form 4 |
| SECZ | Flores Junco Jose Francisco | Chief Financial Officer | 09/10/2026 | Zuteilung | — | 161,140 | — | Form 4 |
| SE | Chen Jingye | CPO, Shopee | 09/10/2026 | Verkauf | 108.50 | 7,606 | 825,251 | Form 4 |
| SE | Chen Jingye | CPO, Shopee | 09/10/2026 | Verkauf | 107.90 | 22,394 | 2,416,313 | Form 4 |
| SE | Ye Gang | COO | 09/10/2026 | Verkauf | 108.54 | 3,901 | 423,415 | Form 4 |
| SE | Ye Gang | COO | 09/10/2026 | Verkauf | 107.92 | 16,099 | 1,737,404 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 09/10/2026 | Verkauf | 108.50 | 255 | 27,668 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 09/10/2026 | Verkauf | 107.85 | 945 | 101,918 | Form 4 |
| SERA | Inglis Tiffany Eul Davis | Chief Medical Officer | 09/10/2026 | Verkauf | 2.00 | 486 | 972 | Form 4 |
| SERA | Anderson Dyaarl Lee Jr. | Chief Commercial Officer | 09/10/2026 | Verkauf | 2.00 | 1,800 | 3,600 | Form 4 |
| SERA | Lindgardt Zhenya | Chief Executive Officer | 09/10/2026 | Verkauf | 2.00 | 7,022 | 14,044 | Form 4 |
| SERA | Jackson Benjamin | General Counsel | 09/10/2026 | Verkauf | 2.00 | 2,190 | 4,380 | Form 4 |
| SELF | Winmill Mark Campbell | President and CEO | 09/10/2026 | Kauf | 5.16 | 292 | 1,507 | Form 4 |
| SELF | Winmill Mark Campbell | President and CEO | 09/10/2026 | Kauf | 5.16 | 50 | 258 | Form 4 |
| SE | Chen Jingye | CPO, Shopee | 09/09/2026 | Verkauf | 111.42 | 700 | 77,994 | Form 4 |
| SE | Chen Jingye | CPO, Shopee | 09/09/2026 | Verkauf | 110.59 | 2,000 | 221,180 | Form 4 |
| SE | Chen Jingye | CPO, Shopee | 09/09/2026 | Verkauf | 109.23 | 9,001 | 983,179 | Form 4 |
| SE | Chen Jingye | CPO, Shopee | 09/09/2026 | Verkauf | 108.41 | 18,299 | 1,983,795 | Form 4 |
| SE | Ye Gang | COO | 09/09/2026 | Verkauf | 111.39 | 500 | 55,695 | Form 4 |
| SE | Ye Gang | COO | 09/09/2026 | Verkauf | 110.57 | 1,200 | 132,684 | Form 4 |
| SE | Ye Gang | COO | 09/09/2026 | Verkauf | 109.21 | 6,300 | 688,023 | Form 4 |
| SE | Ye Gang | COO | 09/09/2026 | Verkauf | 108.41 | 12,000 | 1,300,920 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 09/09/2026 | Verkauf | 111.36 | 36 | 4,009 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 09/09/2026 | Verkauf | 110.56 | 84 | 9,287 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 09/09/2026 | Verkauf | 109.23 | 405 | 44,238 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 09/09/2026 | Verkauf | 108.41 | 795 | 86,186 | Form 4 |
| SELF | Winmill Mark Campbell | President and CEO | 09/09/2026 | Kauf | 5.16 | 2,058 | 10,619 | Form 4 |
| SELF | Winmill Mark Campbell | President and CEO | 09/09/2026 | Kauf | 5.16 | 1,600 | 8,256 | Form 4 |
| SEI | Teague Aj | Director | 09/08/2026 | Kauf | 64.25 | 3,900 | 250,575 | Form 4 |
| SERA | Lindgardt Zhenya | Chief Executive Officer | 09/08/2026 | Verkauf | 2.00 | 20,139 | 40,278 | Form 4 |
| SENEB | Erstad Dean Everett | Senior VP Sales & Marketing | 09/04/2026 | Verkauf | 206.16 | 1,587 | 327,176 | Form 4 |
| SENEA | Erstad Dean Everett | Senior VP Sales & Marketing | 09/04/2026 | Verkauf | 206.16 | 1,587 | 327,176 | Form 4 |
| SEIC | Hicke Ryan | Chief Executive Officer | 09/03/2026 | Verkauf | 110.71 | 37,500 | 4,151,663 | Form 4 |
| SEIC | Hicke Ryan | Chief Executive Officer | 09/03/2026 | Optionsausübung | 64.43 | 20,000 | 1,288,600 | Form 4 |
| SEIC | Hicke Ryan | Chief Executive Officer | 09/03/2026 | Optionsausübung | 48.47 | 17,500 | 848,225 | Form 4 |
| SEZL | Youakim Charles | Executive Chairman and CEO | 09/02/2026 | J | — | 1,508,454 | — | Form 4 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | 09/01/2026 | Verkauf | 37.83 | 3,333 | 126,078 | Form 4 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | 09/01/2026 | Optionsausübung | 2.76 | 3,333 | 9,199 | Form 4 |
| SES | Xu Kang | CHIEF TECHNOLOGY OFFICER | 09/01/2026 | Steuer-Abgabe | 0.523 | 35,198 | 18,409 | Form 4 |
| SEIC | Romeo Carmen | Director | 09/01/2026 | Verkauf | 109.70 | 5,000 | 548,500 | Form 4 |
| SEIC | Romeo Carmen | Director | 09/01/2026 | Optionsausübung | 49.63 | 5,000 | 248,150 | Form 4 |
| SE | Ye Gang | COO | 09/01/2026 | Verkauf | 114.46 | 3,340 | 382,296 | Form 4 |
| SE | Ye Gang | COO | 09/01/2026 | Verkauf | 113.70 | 8,032 | 913,238 | Form 4 |
| SE | Ye Gang | COO | 09/01/2026 | Verkauf | 112.99 | 5,012 | 566,306 | Form 4 |
| SE | Ye Gang | COO | 09/01/2026 | Verkauf | 111.72 | 3,616 | 403,980 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 09/01/2026 | Verkauf | 114.39 | 204 | 23,336 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 09/01/2026 | Verkauf | 113.51 | 416 | 47,220 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 09/01/2026 | Verkauf | 112.87 | 380 | 42,891 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 09/01/2026 | Verkauf | 111.53 | 500 | 55,765 | Form 4 |
| SE | Ye Gang | COO | 08/31/2026 | Verkauf | 117.63 | 200 | 23,526 | Form 4 |
| SE | Ye Gang | COO | 08/31/2026 | Verkauf | 116.42 | 900 | 104,778 | Form 4 |
| SE | Ye Gang | COO | 08/31/2026 | Verkauf | 115.17 | 5,493 | 632,629 | Form 4 |
| SE | Ye Gang | COO | 08/31/2026 | Verkauf | 114.63 | 6,607 | 757,360 | Form 4 |
| SE | Ye Gang | COO | 08/31/2026 | Verkauf | 113.32 | 786 | 89,070 | Form 4 |
| SE | Ye Gang | COO | 08/31/2026 | Verkauf | 112.48 | 6,014 | 676,455 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 08/31/2026 | Verkauf | 117.58 | 18 | 2,116 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 08/31/2026 | Verkauf | 115.86 | 90 | 10,427 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 08/31/2026 | Verkauf | 114.89 | 685 | 78,700 | Form 4 |
| SE | Wang Yanjun | CCO and GC | 08/31/2026 | Verkauf | 114.10 | 89 | 10,155 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).